Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): A 12-week, double-blind, randomized, controlled trial. - Madsbad,S.; Schmitz,O.; Ranstam,J.; Jakobsen,G.; Matthews,D.R. (Diabetes Care, 2004)